A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200
Completed · Phase 1
Conditions studied: Absorption, Metabolism and Excretion in Healthy Volunteers
In brief
This is a Phase 1, open-label non-randomized, single dose study in healthy male subjects.
Key facts
- Study ID
- NCT05238337
- Run by
- Pyramid Biosciences
- People needed
- 6
- Starts
- 2022-02-24
- Expected to finish
- 2022-03-24
- Last updated by the study team
- 2022-08-30
Who can join
Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.
Where it is running
- Labcorp Clinical Research Unit Inc — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.